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Abstract
During viral infection, a massive demand for viral glycoproteins can overwhelm the capacity of the protein folding and
quality control machinery, leading to an accumulation of unfolded proteins in the endoplasmic reticulum (ER). To restore ER
homeostasis, cells initiate the unfolded protein response (UPR) by activating three ER-to-nucleus signaling pathways, of
which the inositol-requiring enzyme 1 (IRE1)-dependent pathway is the most conserved. To reduce ER stress, the UPR
decreases protein synthesis, increases degradation of unfolded proteins, and upregulates chaperone expression to enhance
protein folding. Cytomegaloviruses, as other viral pathogens, modulate the UPR to their own advantage. However, the
molecular mechanisms and the viral proteins responsible for UPR modulation remained to be identified. In this study, we
investigated the modulation of IRE1 signaling by murine cytomegalovirus (MCMV) and found that IRE1-mediated mRNA
splicing and expression of the X-box binding protein 1 (XBP1) is repressed in infected cells. By affinity purification, we
identified the viral M50 protein as an IRE1-interacting protein. M50 expression in transfected or MCMV-infected cells
induced a substantial downregulation of IRE1 protein levels. The N-terminal conserved region of M50 was found to be
required for interaction with and downregulation of IRE1. Moreover, UL50, the human cytomegalovirus (HCMV) homolog of
M50, affected IRE1 in the same way. Thus we concluded that IRE1 downregulation represents a previously undescribed viral
strategy to curb the UPR.
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Introduction
During viral replication large amounts of viral proteins must be
synthesized, folded, and posttranslationally modified. Folding,
maturation and multi-subunit assembly of secreted and trans-
membrane proteins take place in the endoplasmic reticulum (ER)
and require an elaborate system of chaperones, lectins, and
carbohydrate-processing enzymes. Whereas correctly folded pro-
teins are transported to the Golgi, misfolded or unfolded proteins
are arrested in the ER and diverted for degradation via the ER-
associated protein degradation (ERAD) pathway [1]. However,
the high levels of viral envelope glycoproteins that are being
synthesized particularly during the late phase of the viral life cycle
can overwhelm the folding and processing capacity of the ER and
cause accumulation of unfolded and misfolded proteins in the ER
[2]. In addition, large quantities of secreted and immunomodu-
latory viral proteins can contribute to ER stress [3]. To reduce
protein load and restore ER homeostasis, eukaryotic cells activate
various ER-to-nucleus signaling pathways, which are collectively
referred to as Unfolded Protein Response (UPR) [4,5]. The UPR
is initiated by three sensor proteins that recognize ER stress:
protein kinase R-like ER kinase (PERK), activating transcription
factor 6 (ATF6), and inositol-requiring enzyme 1 (IRE1). The ER
chaperone BiP (immunoglobulin heavy chain binding protein),
also known as glucose-regulated protein 78, is thought to bind
these sensors and keep them inactive under normal conditions.
However, when unfolded and misfolded proteins accumulate in
the ER, BiP dissociates from these sensors to perform its
chaperone function. As a consequence, the sensors are activated
and initiate UPR signaling. Activation of PERK leads to
phosphorylation of the a subunit of eukaryotic translation
initiation factor 2 (eIF2a), resulting in global attenuation of
protein translation [6,7]. However, if ER stress persists eIF2a
initiates expression of activating transcription factor 4 (ATF4),
which induces expression of the proapoptotic transcription factor
C/EBP-homologous protein (CHOP, also known as growth arrest
and DNA damage-inducible protein 153). CHOP expression
promotes apoptosis by downregulating the antiapoptotic protein
Bcl-2 [8,9]. Activated ATF6 translocates to the Golgi where it is
cleaved by site 1 and site 2 proteases [10]. The active transcription
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factor is imported into the nucleus where it induces transcription
of chaperone genes [11]. The IRE1 pathway is the most conserved
branch of the UPR [12]. Mammalian cells encode two IRE1
isoforms, IRE1a and IRE1b. IRE1a, the most abundant isoform,
is expressed in most cells and tissues and is hereafter referred to as
IRE1. By contrast, IRE1b (also known as IRE2) is expressed to
significant levels only in intestinal epithelial cells [13]. Upon
activation, IRE1 dimerizes and transphosphorylates itself. This
leads to activation of a site-specific endoribonuclease activity in the
cytosolic tail of IRE1, which mediates an unconventional splicing
of the X-box binding protein 1 (XBP1) mRNA in the cytosol
[14,15]. The transcription factor XBP1s, which is translated from
the spliced Xbp1 transcript, translocates to the nucleus and induces
expression of ERAD enzymes [1,12]. If ER stress is too severe to
overcome and ER homeostasis cannot be restored, IRE1 can also
activate c-Jun N-terminal kinase (JNK) to commit damaged cells to
apoptosis [16].
Increasing evidence indicates that viruses selectively modulate
the UPR to take advantage of the beneficial effects and inhibit
those detrimental to viral replication [2]. For instance, hepatitis C
virus and other members of the Flaviviridae activate beneficial
components of the UPR such as BiP in certain cell types to
facilitate their replication but trigger ER stress-induced apoptosis
in other cells [17–20]. Members of the Herpesviridae also modulate
the UPR to their own advantage. The molecular mechanisms,
however, appear to differ from one virus to another [21]. For
example the viral glycoprotein gB of herpes simplex virus type 1
(HSV-1) inhibits PERK activation [22]. By contrast, varicella-
zoster virus, another alphaherpesvirus, activates the PERK and
IRE1 pathways [23]. UPR modulation also takes place in
gammaherpesvirus-infected cells. Epstein-Barr virus (EBV) latent
membrane protein 1 activates PERK to enhance its own
expression [24]. In addition, reactivation of EBV from latent
infection is induced by extrinsic ER stress while XBP1 induces
EBV lytic gene expression [25]. From these and other examples it
has been concluded that UPR regulation plays an important role
in viral infection and pathogenesis [2].
Several studies have investigated the ability of human
cytomegalovirus (HCMV), a betaherpesvirus, to cope with ER
stress and manipulate the UPR to its own benefit. HCMV is a
major hazard for immunocompromised individuals such as
transplant recipients and the leading infectious cause of birth
defects [26]. To enhance viral replication HCMV has adopted
several strategies to modulate the UPR. For example, HCMV
induces PERK activation, but limits eIF2a phosphorylation. By
doing this the virus prevents a global protein synthesis shutoff but
allows eIF2a phosphorylation-dependent activation of transcrip-
tion factor ATF4 [27]. HCMV also uses PERK to induce
lipogenesis by activating the cleavage of sterol regulatory element
binding protein 1 [28]. In addition, HCMV increases expression
of the ER chaperone BiP to facilitate protein folding and virion
assembly [29,30]. Moreover, the viral UL38 protein was shown to
prevent ER stress-induced JNK activation and apoptosis [31]. A
recent study has revealed that murine cytomegalovirus (MCMV),
a related betaherpesvirus, influences the UPR in a similar manner
[32]. Particularly, MCMV was shown to activate the PERK–
ATF4 pathway and upregulate expression of the ER chaperone
BiP. However, in most cases the exact mechanisms by which
human and murine cytomegaloviruses modulate the UPR remain
undefined.
In the present study, we investigated the influence of MCMV
infection on the IRE1 pathway. This pathway has been
characterized in yeast as well as in mammalian cells and represents
the most evolutionary conserved branch of the UPR [5]. IRE1
mediates an unconventional splicing of Xbp1, which in turn
triggers expression of ERAD proteins [33]. We discovered an
interaction between IRE1 and the viral protein M50. The viral
M50 was previously characterized as a type II transmembrane
(TM) protein that associates with the viral M53 protein. M50 and
M53 are essential components of a complex that dissolves the
nuclear lamina [34]. Proteins homologous to M50 are found in all
herpesviruses studied thus far, and these proteins are involved in
nuclear egress of viral capsids. Moreover, M50 and its homologs
are essential for lytic replication of beta- and gammaherpesviruses
[35,36]. We show that M50 expression induces a robust down-
modulation of IRE1 levels in transfection and infection experi-
ments suggesting that M50 induces IRE1 degradation. The N-
terminal conserved region of M50 proved to be required for IRE1
binding and degradation. We further showed that UL50, the
HCMV homolog of M50, has a similar function. We propose that
inhibition of IRE1 signaling by removal of the sensor IRE1
represents a previously unrecognized viral strategy to curb the
UPR.
Results
MCMV inhibits the IRE1-dependent UPR branch
As it has been shown that cytomegaloviruses inhibit the IRE1-
dependent UPR pathway by an unknown mechanism [27,32], we
wanted to investigate how MCMV modulates this pathway. First,
we measured Xbp1 mRNA splicing during MCMV infection by
semiquantitative RT-PCR and real-time RT-PCR. Since the 26 nt
intron, which is spliced out by IRE1, contains a PstI restriction site
[14,15], only the unspliced RT-PCR product is cleaved by PstI.
MCMV infection of NIH-3T3 fibroblasts induced a slight and
transient increase in Xbp1 splicing similar to the one induced by
treatment with a very low dose of tunicamycin (Tun), an
established ER stress inducer (Fig. 1A and B). The ratio of spliced
to unspliced transcripts returned almost to baseline levels around
8 hours postinfection (hpi) and remained constant until 48 hpi. To
test whether MCMV actively suppresses Xbp1 splicing, we treated
MCMV-infected fibroblasts with Tun and measured Xbp1 splicing.
As shown in Figure 1C and D, Tun-induced Xbp1 splicing was
Author Summary
Viruses abuse the cell’s protein synthesis and folding
machinery to produce large amounts of viral proteins. This
enforced synthesis overloads the cell’s capacity and leads
to an accumulation of unfolded proteins in the endoplas-
mic reticulum (ER) resulting in ER stress, which can
compromise cell viability. To restore ER homeostasis, cells
initiate the unfolded protein response (UPR) to reduce
protein synthesis, increase degradation of unfolded pro-
teins, and upregulate chaperone expression for enhanced
protein folding. The most conserved branch of the UPR is
the signaling pathway activated by the ER stress sensor
IRE1. It upregulates ER-associated degradation (ERAD),
thereby antagonizing ER stress. Some of the counter-
regulatory mechanisms of the UPR are detrimental for viral
replication and are, therefore, moderated by viruses. In this
study we identified the first viral IRE1 inhibitor: The murine
cytomegalovirus M50 protein, which interacts with IRE1
and induces its degradation. By this means, M50 inhibits
IRE1 signaling and prevents ERAD upregulation. Interest-
ingly, the M50 homolog in human cytomegalovirus, UL50,
also downregulated IRE1 revealing a previously unknown
mechanism of viral host cell manipulation.
IRE1 Downregulation by CMV
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strongly reduced at 24 hpi and almost completely blocked at
48 hpi. A similar inhibition of Xbp1 splicing was observed when
infected cells were treated with the ER stress inducer thapsigargin
(Fig. 1E). We also determined the protein levels of transcription
factor XBP1s by immunoblot analysis. Consistent with the RT-
PCR results, Tun-induced XBP1s protein expression was inhibited
Figure 1. MCMV modulates Xbp1 splicing. (A) NIH-3T3 cells were infected with MCMV at an MOI of 5 or treated with tunicamycin (Tun) for 4 h.
Xbp1 mRNA transcripts were amplified by RT-PCR, digested with PstI, and separated on an ethidium bromide-stained agarose gel. The spliced
transcript, Xbp1s, lacks the PstI site and migrates slower than the digested unspliced transcript, Xbp1u. (B) NIH-3T3 cells were treated as described for
panel A. Xbp1s and Xbp1u transcripts were quantified by real-time RT-PCR. Changes in the Xbp1s/Xbp1u ratio relative to untreated cells are plotted as
bar diagram showing means 6SEM of four replicates. (C) NIH-3T3 cells were infected as above and treated in addition with Tun for the last 4 h before
harvest. Xbp1 transcripts were analyzed as in A. (D) NIH-3T3 cells were treated as in C, and Xbp1 transcripts were quantified as in B. (E) NIH-3T3 cells
were MCMV-infected and treated with thapsigargin (Tg) for the last 4 h before harvest. Xbp1 transcripts were quantified as in B. (F) NIH-3T3 cells were
MCMV-infected and treated with Tun for the last 4 h before harvest. Nuclear protein extracts were analyzed by immunoblot for the presence of XBP1s
protein. Heterochromatin protein 1a (HP1a) was used as a loading control. (G) NIH-3T3 cells were infected with MCMV at an MOI of 5 and treated
with Tun for 4 h. ERdj4 transcripts were quantified by real-time RT-PCR. Results are shown as fold induction relative to untreated cells (means 6SEM
of four replicates).
doi:10.1371/journal.ppat.1003544.g001
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at 24 and almost completely blocked at 48 hpi (Fig. 1F). Moreover,
ER stress-induced transcription of the XBP1s target gene ERdj4,
which encodes an ERAD protein [37], was also inhibited (Fig. 1G),
further confirming the conclusion that MCMV actively inhibits
the IRE1 pathway at late times postinfection.
MCMV M50 interacts with IRE1
As activated IRE1 is the only enzyme mediating Xbp1 mRNA
splicing, we hypothesized that MCMV might express a protein
that interacts with IRE1. To identify IRE1 interaction partners,
we stably transfected NIH-3T3 cells with a plasmid encoding
IRE1 with a C-terminal tobacco etch virus (TEV) protease
cleavage site and an HA epitope tag. IRE1-TEV-HA-expressing
cells were infected with MCMV, and protein lysates were loaded
onto an anti-HA affinity matrix. After washing, IRE1 was released
from the matrix by TEV protease digestion. Eluted proteins were
separated by gel electrophoresis and silver stained (Fig. 2A). Bands
not present in the control lane (uninfected cells) were excised and
analyzed by protein mass spectrometry. In an approx. 32 kDa
band two MCMV proteins were identified: M50 and M85. M50 is
a type II transmembrane (TM) protein with a C-terminal TM
anchor. It is found in the ER membrane and the nuclear envelope
and is known to play a crucial role in nuclear egress of viral capsids
[34,38–40]. M85 is the MCMV minor capsid protein [41] and is
not known to be associated with ER membranes. To confirm or
dismiss the two MCMV proteins as specific interaction partners of
IRE1, HEK 293 cells were transfected with expression plasmids
encoding HA-tagged IRE1 and Flag-tagged MCMV proteins.
Flag-tagged M50 coprecipitated with IRE1-HA, and IRE1-HA
coprecipitated with M50-Flag (Fig. 2B and C). IRE1 did not
interact with Flag-tagged m144 or Calnexin (CNX), two ER-
localized control proteins. IRE1 also did not interact with Flag-
tagged M85 in co-immunoprecipitation experiments (data not
shown). Therefore, M85 was not further investigated as a
modulator of the IRE1 signaling pathway.
Next we tested whether IRE1 interacts with M50 during
MCMV infection. As endogenous IRE1 is expressed at low levels
and is difficult to analyze, we used cells expressing epitope-tagged
IRE1 from a retroviral vector – a procedure used in several
previous studies [42,43]. 10.1 fibroblasts stably expressing myc-
tagged IRE1 were infected with MCMV mutants expressing HA-
tagged M50 (MCMV-M50HA) or HA-tagged m41 (MCMV-
HAm41). Cell lysates were harvested 17 and 31 hpi and subjected
to immunoprecipitation and immunoblot analyses. Fig. 2D shows
that M50 coprecipitated with IRE1, consistent with the affinity
purification experiment (Fig. 2A), but m41, an unrelated MCMV
type 2 TM protein [44], did not. Likewise, HA-tagged M50, but
not m41, interacted with endogenous IRE1 in MCMV-infected
NIH-3T3 cells (Fig. 2E).
M50 colocalizes with IRE1
Next we analyzed the subcellular localization of IRE1 and M50
by immunofluorescence (IF). To do this, we cotransfected cells
with expression plasmids for IRE1 and M50 or UL56, an
unrelated type 2 TM protein of Herpes Simplex Virus type 1 [45].
As shown in Figure 3A, IRE1 and M50 colocalized in transfected
NIH-3T3 cells, but IRE1 and UL56 did not.
We also tested whether IRE1 and M50 colocalize in MCMV-
infected fibroblasts. As M50 is a late protein, infected cells had to
be fixed and stained at late time points, but not too late in order to
avoid cell rounding and detachment as a result of the MCMV-
induced cytopathic effect. Moreover, M50 is known to change its
localization during MCMV infection: it first localizes to the ER,
but is subsequently redistributed to the nuclear rim as a
consequence of its interaction with the nuclear MCMV protein
M53 [34,40]. When we infected 10.1 fibroblasts expressing myc-
tagged IRE1 with MCMV-M50HA, we saw that a substantial
portion of M50 retained a cytoplasmic distribution despite an
obvious accumulation at the nuclear rim, and this portion of M50
colocalized with IRE1 (Fig. 3B). We also noticed that IRE1 levels
appeared to be reduced at late times in MCMV-infected cells
compared to neighboring uninfected cells (Fig. 3B, 20 hpi).
To rule out the possibility that the detection of HA-tagged M50
in the cytoplasm resulted from an unspecific binding of the anti-
HA antibody to MCMV-infected cells, fibroblasts were infected
with wt MCMV or MCMV-M50HA and subjected to IF analysis.
Using the same anti-HA antibody and the same staining
conditions, a cytoplasmic staining was detected only in MCMV-
M50HA-, but not in wt MCMV-infected cells (Fig. 3C).
M50 expression reduces IRE1 protein levels
Next we investigated whether M50 inhibits IRE1 phosphory-
lation, which is required for activation of its endoribonuclease
activity. To do this, we transfected NIH-3T3 cells with an IRE1
expression plasmid and cotransfected increasing amounts of an
M50 or an m144 expression plasmid. Overexpression of IRE1 is
known to cause its activation by autotransphosphorylation [46]. As
shown in figure 4A, the levels of phosphorylated IRE1 decreased
with increasing M50 expression but not with increasing expression
of the m144 control protein. Moreover, total IRE1 levels were also
decreased, indicating that M50 reduces IRE1 levels rather than
just inhibiting its activation. Nevertheless, IRE1 phosphorylation
might be required for its downregulation. To test this hypothesis,
NIH-3T3 cells were cotransfected with expression plasmids for
M50 and either wildtype (wt) IRE1 or a kinase-inactive mutant
(K599A). As expected, overexpressed IRE1 K599A was not
phosphorylated. However, it was downregulated by M50 just like
wt IRE1 (Fig. 4B). Thus we concluded that IRE1 downregulation
is independent of its phosphorylation.
As M50 also interacts with the viral M53 protein at the nuclear
envelope, we tested whether M53 expression affects the M50-
induced IRE1 downregulation. NIH-3T3 cells were cotransfected
with plasmids encoding IRE1, M50, and M53. As shown in figure
S1, M50 expression induced IRE1 downregulation also in the
presence of M53. However, downregulation was reduced when
larger amounts of M53 expression plasmid were cotransfected,
suggesting that M53 and IRE1 compete for binding to M50.
To check whether IRE1 was also downregulated during
MCMV infection, IRE1 levels were determined in an infection
time course experiment. Figure 4C shows that IRE1 levels
decreased during the course of infection as M50 levels increased.
The observed IRE1 downregulation is consistent with the
inhibited Xbp1 splicing in normal fibroblasts, which express only
endogenous IRE1 (Fig. 1)
Next we investigated whether IRE1 downregulation occurred at
the transcriptional level. RNA was isolated from MCMV-infected
cells and Ire1 transcripts were quantified by real-time RT-PCR.
The results showed that Ire1 transcripts did not decrease but rather
increased slightly during the course of MCMV infection (Fig. 4D),
indicating that IRE1 downregulation occurred at the posttran-
scriptional level.
We then tested whether M50 induces IRE1 degradation. To do
this, HEK 293 cells were cotransfected with M50 and IRE1
expression plasmids, and IRE1 stability was determined by pulse-
chase analysis. Indeed, IRE1 stability was reduced significantly
when M50 was coexpressed (Fig. 4E and F), strongly suggesting
that M50 induces IRE1 degradation. To test whether ubiquityla-
tion was necessary for IRE1 degradation, IRE1 and M50 were
IRE1 Downregulation by CMV
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coexpressed in ts20 cells, which have a temperature sensitive E1
ubiquitin-activating enzyme [47]. In these cells, M50 expression
reduced IRE1 levels at both the permissive and restrictive
temperatures (Fig. S2A), suggesting that ubiquitin conjugation
was not required. The IRE1 downregulation seen in immunoblot
experiments was also not inhibited by proteasome inhibitors
MG132 or lactacystin (Fig. S2B). We also investigated whether
IRE1 degradation could be inhibited by lysosomal protease
inhibitors (PI) or NH4Cl, an inhibitor of lysosome acidification.
Neither NH4Cl nor a PI cocktail inhibited IRE1 downregulation
by M50 (Fig. S2C). Collectively these data suggested that IRE1 is
degraded neither by the proteasome nor in lysosomes but rather
cleaved by another cellular protease. It is also conceivable that
lysosomal proteases that are not inhibited by these drugs are
responsible for IRE1 degradation.
The M50 conserved region is required for IRE1
downregulation
M50 consists of an N-terminal conserved region, a variable
region, a TM domain, and a short C-terminal tail [39]. The
Figure 2. MCMV M50 interacts with IRE1. (A) NIH-3T3 cells stably expressing TEV-HA-tagged IRE1 were mock infected or infected with MCMV at
an MOI of 5. Whole cell lysates (WCL) were applied to an anti-HA sepharose matrix. IRE1 and interacting proteins were eluted by TEV protease
digestion, separated by SDS-PAGE, and silver stained. Specific bands (arrow heads) were excised and analyzed by protein mass spectrometry. (B) 293A
cells were cotransfected with expression plasmids for IRE1-HA and Flag-tagged M50, m144, or Calnexin (CNX), respectively. IRE1 was subjected to
immunoprecipitation (IP) with an anti-HA antibody. IRE1 and coexpressed proteins were detected by immunoblot in IP samples and WCL using anti-
HA and anti-Flag antibodies, respectively. (C) 293A cells were cotransfected with expression plasmids for IRE1-HA and Flag-tagged M50 or m144,
respectively. M50 and m144 were precipitated with an anti-Flag antibody. IRE1 and coexpressed proteins were detected in IP samples and WCL as
described above. (D) 10.1 fibroblasts transduced with a retroviral vector expressing myc-tagged IRE1 were infected with an MCMV expressing HA-
tagged M50 or m41 at an MOI of 4. At the indicated time points IRE1 was immunoprecipitated with an anti-myc antibody, and HA-tagged proteins
were detected by immunoblot. (E) NIH-3T3 cells were infected with the same viruses as in D. After 24 h, M50 and m41 proteins were
immunoprecipitated with an anti-HA antibody. IRE1 was detected in IP samples and WCL using an IRE1-specific antibody.
doi:10.1371/journal.ppat.1003544.g002
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Figure 3. Intracellular localization of IRE1 and M50. (A) NIH-3T3 cells were cotransfected with expression plasmids for IRE1-HA and Flag-tagged
M50 or UL56 respectively. 24 h post transfection, cells were fixed and subjected to immunofluorescence staining using HA- and Flag-specific
antibodies. Cell nuclei were stained with Draq5. The Pearson correlation coefficient (PC) was determined for transfected cells. (B) 10.1 cells stably
expressing IRE1-3xmyc were infected with MCMV-M50HA. At 16, 18, and 20 hpi cells were fixed and subjected to immunofluorescence staining using
myc- and HA-specific antibodies. (C) 10.1 cells were infected with wt MCMV or MCMV-M50HA. Cells were fixed 20 hpi and stained with the same anti-
HA antibody as in B and an antibody against the viral IE1 protein.
doi:10.1371/journal.ppat.1003544.g003
Figure 4. M50 expression reduces IRE1 protein levels. (A) NIH-3T3 cells were cotransfected with plasmids encoding IRE1-HA (1 mg) and Flag-
tagged M50 or m144 (0.5, 1, or 2 mg). After 24 h, cell lysates were analyzed by immunoblot using protein- or tag-specific antibodies. (B) NIH-3T3 cells
were cotransfected with plasmids encoding M50 (2 or 3 mg) and wildtype IRE1 or the K599A kinase-dead IRE1 mutant (1 mg). Cells were analyzed by
immunoblot as described above. (C) 10.1 cells transduced with an IRE1-HA-expressing retroviral vector were infected with MCMV at an MOI of 5. Cells
were harvested at the indicated time points, and IRE1, M50, and actin levels were determined by immunoblot using protein- or tag-specific
antibodies. (D) NIH-3T3 fibroblasts were infected with MCMV at an MOI of 5. RNA was isolated at the indicated time points, and Ire1 transcripts were
quantified by real-time RT-PCR. Means 6SEM of three replicates are shown relative to uninfected cells. (E) 293T cells were cotransfected with
expression plasmids for IRE1-HA and M50. After pulse-chase labeling with [35S]methionine, IRE1 was immunoprecipitated with an anti-HA antibody
and analyzed by autoradiography. (F) Signals in blot E were quantified by densitometry relative to the 0 h chase value.
doi:10.1371/journal.ppat.1003544.g004
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N-terminal region is conserved among the herpesviruses, particularly
those of the same subfamily [48]. To determine which parts of M50
are required for IRE1 downregulation, a number of N- and C-
terminal truncation mutants and mutants with internal deletions
were constructed (Fig. 5A). These mutants were tested for their
ability to downregulate IRE1 levels and interact with IRE1. In
cotransfection experiments, M50 mutants lacking the entire
conserved region were unable to downregulate IRE1, whereas
mutants lacking only a part of the conserved or the variable region
downregulated IRE1 (Fig. 5B). The 141–317 mutant repeatedly
displayed an intermediate phenotype, i.e. a moderate downregula-
tion of IRE1. Truncated M50 proteins lacking up to 140 aa from the
N-terminus coprecipitated with IRE1, but mutants lacking the entire
conserved region did not (Fig. 5C). The M50 1–276 mutant, which
lacks the TM domain, was also incapable of downregulating IRE1
(Fig. 5B) but coprecipitated with IRE1 (Fig. S3A) and colocalized, at
least partially, with IRE1 in transfected cells (Fig. S3B). However,
when the M50 TM domain was substituted by the TM domain of an
unrelated type 2 TM protein, HSV-1 UL56, IRE1 downregulation
was restored, suggesting that the M50 protein needs a TM anchor
for IRE1 downregulation but not for interaction with IRE1.
M50 downregulates IRE1 during MCMV infection
We wanted to test whether M50 is responsible for the IRE1
downregulation observed in MCMV-infected cells (Fig. 4C). This
could be done with an MCMV M50 deletion mutant or a virus
mutant expressing an M50 protein lacking the conserved region.
Unfortunately, M50 is essential for MCMV replication as it
mediates, together with M53, nuclear egress of viral capsids [34].
The conserved region of M50, which mediates interaction with
IRE1 (Fig. 5), is also required for its interaction with M53 [38,39].
Until recently, all attempts to generate M50 trans-complementing
cell lines for the propagation of an M50-deficient MCMV had failed
because stable M50 expression was not tolerated by cells [34]. This
Figure 5. Identification of the region required for IRE1 binding and degradation. (A) Schematic representation of the mutant M50 proteins
used in the following experiments. Proline-rich (P) sequence, transmembrane (TM) domain, and the peptide recognized by the M50-specific antibody
(ab) are indicated. Numbers on the right indicate amino acid positions. The HSV-1 UL56 protein was used as an unrelated control protein. 56TM is an
M50 mutant containing the TM domain of HSV-1 UL56. (B) NIH-3T3 cells were cotransfected with plasmids coding for IRE1-HA (1 mg) and the proteins
shown in panel A (2 mg). After 24 h, IRE1 levels were analyzed by immunoblot using an anti-HA antibody. M50 mutants and UL56 were detected with
M50- and Flag-specific antibodies. (C) 293A cells were cotransfected with expression plasmids for IRE1-HA and full-length (fl.) or mutant M50. IRE1
was immunoprecipitated (IP) with an anti-HA antibody, and coprecipitating M50 proteins were detected by immunoblot using an M50-specific
antibody. The same proteins were detected in whole cell lysates (WCL). LC, antibody light chain.
doi:10.1371/journal.ppat.1003544.g005
IRE1 Downregulation by CMV
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obstacle was recently overcome with an MCMV-inducible expres-
sion system based on an episomal replicating plasmid containing the
MCMV origin of lytic replication and the M50 gene [49]. In NIH-
3T3 cells stably carrying this plasmid M50 expression was silenced.
Upon MCMV infection, however, the vector was replicated and
M50 expression was strongly induced. An MCMV mutant lacking
M50 (MCMVDM50) could be propagated on these trans-comple-
menting cells [49] and used for further experiments. When we
infected 10.1 fibroblasts stably expressing myc-tagged IRE1 with
MCMVDM50 or the parental control virus, we observed a strong
downregulation of IRE1 levels by the parental MCMV, but only a
slight reduction by the MCMVDM50 virus (Fig. 6A). MCMV
infection caused a modest reduction of Ire1 transcripts in these cells
(Fig. S4). This reduction was seen for both viruses, indicating that
M50 is not responsible for this effect. However, it is possible that the
slightly reduced IRE1 protein levels observed in MCMVDM50-
infected cells (Fig. 6A) were caused by reduced Ire1 transcription. In
NIH-3T3 fibroblasts (expressing only endogenous IRE1), splicing of
Xbp1 transcripts and transcription of ERdj4 was strongly inhibited
upon infection with the MCMV control virus, but only moderately
diminished upon infection with MCMVDM50 (Fig. 6B and C).
These results showed that M50 is primarily responsible for
inhibition of the IRE1-XBP1 pathway during MCMV infection.
However, the moderate reduction in Xbp1 mRNA splicing and
ERdj4 transcription in MCMVDM50-infected cells suggest that
additional mechanisms contribute to the inhibition of the IRE1-
XBP1 signaling pathway.
HCMV UL50 interacts with IRE1 and mediates IRE1
downregulation
M50 is a protein conserved among the Herpesviridae family, and
the functional conservation was reported to be particularly strong
among members of the same subfamily [48]. Hence we tested
whether UL50, the HCMV homolog of M50, has a similar
function. Indeed, UL50 coimmunoprecipitated with IRE1 like
M50 did (Fig. 7A), and UL50 expression downregulated IRE1
levels in transfected cells (Fig. 7B). Moreover, IRE1 levels in
HCMV-infected fibroblasts decreased over time (Fig. 7C), and this
decrease correlated with a suppression of Xbp1 splicing following
Tun treatment (Fig. 7D). Therefore we concluded that the novel
function of M50 described in this report is not unique for MCMV
but conserved in the related human pathogen, HCMV.
Discussion
In this study we showed that MCMV and HCMV repress
IRE1-mediated ER-to-nucleus signaling, the most conserved
branch of the UPR (Fig. 8A). The viral proteins M50 and
UL50, respectively, interact with IRE1 and downregulate IRE1
levels in transfected or infected cells (Fig. 8B). Thereby, IRE1-
mediated Xbp1 mRNA splicing, synthesis of transcription factor
XBP1s, and expression of XBP1s target genes are inhibited. These
results are consistent with two previous studies, which have
reported an inhibition of EDEM (an XBP1s target gene)
expression by HCMV [27] and a block to Xbp1 mRNA splicing
by MCMV [32], respectively. In these studies, the underlying
mechanism of these effects and the viral proteins involved were not
investigated. However, other previous studies have shown that
HCMV upregulates the ER chaperone BiP through increased
transcription and activation of translation by using the BiP internal
ribosome entry site [29,30]. BiP was shown to be important for
HCMV virion assembly [29]. Moreover, since BiP binds to the ER
stress sensors PERK, ATF6, and IRE1 and keeps them inactive, it
has been suggested that BiP upregulation might also dampen the
UPR [29]. We and others have also observed BiP upregulation in
MCMV-infected cells (Fig. S5 and [32]), and this effect might in
fact be responsible for the moderate inhibition of Xbp1 splicing and
ERdj4 transcription observed in MCMVDM50-infected cells
(Fig. 6B and C). It should also be noted that an interaction
between UL50 and BiP has been described in a previous study
[50]. It remains to be investigated whether UL50 interacts with
BiP directly or rather indirectly via IRE1. Collectively, the data of
the present and previous studies suggest that M50/UL50 and
increased BiP levels have a synergistic inhibitory effect on the
IRE1-dependent signaling pathways.
Apart from the strong inhibition of the IRE1-XBP1 axis at late
times postinfection, MCMV infection causes a modest induction of
Xbp1 mRNA splicing at very early times after infection (Fig. 1B,
2 hpi), which decreases within the following hours. The cause of
this modest effect was not investigated in this study and remains
unknown. It is unlikely that viral glycoprotein expression is
responsible for this very early induction of Xbp1 mRNA splicing as
viral glycoproteins are not expressed in large quantities so early
after infection. However, it is possible that the high-MOI infection
itself causes ER stress, for instance, by inducing a rapid and
transient Ca2+ release from the ER as it has been described for
HSV-1 infection [51]. It also remains unknown whether the initial
ER stress induction occurs only transiently, or whether it is actively
inhibited by a virally induced mechanism. M50 is expressed only
at late times and becomes detectable around 16 hpi (Fig. 3B). By
contrast, BiP upregulation starts already 8 to 12 hpi (Fig. S5) and
might contribute to inhibition of the very early Xbp1 splicing.
By downregulating IRE1 the CMVs can avoid cellular
responses that are likely detrimental for viral replication. Many
XBP1s target genes encode ERAD proteins, which reduce the
protein load in the ER by enhancing ER-associated protein
degradation [1]. Particularly in the late phase of the viral
replication cycle, when large quantities of viral glycoproteins are
needed for progeny production, this counter-regulatory mecha-
nism should have a negative impact on viral replication. XBP1s
has also been reported to enhance interferon b production in
dendritic cells [52], providing another good reason for the virus to
block the IRE1-XBP1 pathway. Moreover, IRE1 has a role in
several other pathways: Besides Xbp1 mRNA splicing, its
endoribonuclease activity also mediates cleavage and inactivation
of glycoprotein-encoding mRNAs [53] as well as certain micro-
RNAs [54] (Fig. 8C). In addition, IRE1 can initiate ER stress-
induced programmed cell death by recruiting the adaptor protein
TRAF2 and activating caspase-12 or JNK [16,55,56] (Fig. 8D).
Activated JNK phosphorylates and inhibits the antiapoptotic Bcl-2
and activates proapoptotic BH3 proteins [57,58]. One can assume
that the viral mediated downregulation of IRE1, which we
described in this study, inhibits all IRE1-dependent pathways.
However, further in-depth studies will be necessary to fully
characterize all consequences of IRE1 downregulation by M50/
UL50 and a potential synergism with UL38, an HCMV protein
that inhibits ER stress-induced JNK activation and apoptosis [31].
While it is clear that M50 interacts with IRE1 and downreg-
ulates IRE1 levels by reducing its half-life, the exact mechanism of
IRE1 removal remains to be determined. As viruses often abuse
host mechanisms for their own benefit, it is possible that the CMVs
activate a cellular IRE1-inhibiting mechanism. For instance, the
cellular BAX inhibtor-1 (BI-1) protein interacts with IRE1 and
inhibits the IRE1-XBP1 signaling pathway [59]. However, BI-1
has not been reported to downregulate IRE1 protein levels,
indicating that M50 and UL50 operate in a different manner. By
contrast, the cellular protein synoviolin interacts with IRE1 and
induces its ubiquitylation and degradation by the proteasome [60].
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It remains to be determined whether or not M50 and UL50
operate in a similar fashion. However, the viral mediated IRE1
downregulation appears to be stronger than the one reported for
synoviolin, and the preserved IRE1 downregulation by M50 in the
presence of proteasome inhibitors and in ubiquitylation-deficient
cells (Fig. S2) argue for a proteasome-independent mechanism.
Besides its effect on IRE1, M50 has an essential role in the
export of viral capsids through the nuclear envelope. It interacts
with the nuclear-localized M53 protein and facilitates primary
envelopment at the inner nuclear membrane [34]. It should be
worthwhile to separate the functions of M50 in capsid export and
IRE1 inhibition in order to study them separately during viral
infection. This is probably a very challenging task as both
functions require the conserved N-terminal domain. However,
with a suitable mutant virus one could investigate the importance
of IRE1 inhibition for CMV replication in cell culture as well as in
the mouse model.
The essential function of M50 in nuclear egress is highly
conserved not only among the CMVs, but among all herpesviruses
analyzed thus far [35,36]. Hence it would be interesting to
investigate whether the IRE1-downregulating function of M50
and UL50 is also conserved beyond the betaherpesviruses. Clearly,
increasing evidence argues for additional, nuclear egress-unrelated




NIH-3T3 (ATCC CRL-1658), 10.1 [62], 293T (ATCC CRL-
11268); 293A (Invitrogen), telomerase-immortalized human fore-
skin fibroblasts (HFF) [63], ts20 cells [47], and MRC-5 (ATCC
CCL-171) cells were grown under standard conditions in
Dulbecco’s modified Eagle’s medium supplemented with 5%
neonatal or 10% fetal calf serum, 100 units/ml penicillin, and
100 mg/ml streptomycin.
Wildtype MCMV, MCMV-GFP [64], MCMV-M50HA [40],
and MCMV-HAm41 [65] were grown and titrated on 10.1
fibroblasts. HCMV AD169-GFP [66] was grown and titrated on
HFF. MCMVDM50 and the corresponding control virus were
propagated and titrated on M50-complementing cells as described
[49]. Viral titers were determined using the median tissue culture
infective dose (TCID50) method [67].
Plasmids and reagents
Plasmids pcDNA-hIRE1a and pCMVTAG-NEMO were
purchased from Addgene, pCR3-IgM53 [34] was provided by
Walter Muranyi. For pcDNA-IRE1-TEV-HA, the murine IRE1a
cDNA was PCR-amplified (introducing the TEV-HA sequence
with the reverse primer) and inserted between the EcoRI and
XbaI sites of pcDNA3 (Invitrogen). The IRE1-TEV-HA sequence
was also cloned in pBRep, an episomal replicating plasmid vector
Figure 6. M50 is required for IRE1 downregulation and
inhibition of Xbp1 splicing during MCMV infection. (A) 10.1
fibroblasts stably expressing myc-tagged IRE1 were infected with an
MCMV M50 deletion mutant (DM50) or the parental control virus at an
MOI of 3. Cells were harvested at 0, 24, and 48 hpi. IRE1 and M50
expression was determined by immunoblot. The viral immediate-early 1
(IE1), the viral late protein M55/gB, and cellular b-actin were used as
infection and loading controls, respectively. (B) Normal 10.1 fibroblasts
were infected as described above and treated for 4 h with Tun. Spliced
and unspliced Xbp1 transcripts were quantified by real-time RT-PCR.
Changes in the spliced/unspliced ratio relative to untreated cells are
plotted as bar diagram showing means 6SEM of four replicates. (C)
ERdj4 transcripts were quantified in the same cell by real-time RT-PCR.
Results are shown as fold induction relative to untreated cells (means
6SEM of three replicates). Significance was determined using the
Student’s t-test. *, p,0.5; **, p,0.01; ***, p,0.001; ns, not significant.
doi:10.1371/journal.ppat.1003544.g006
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[68]. Plasmids pcDNA-hIRE1-HA, pcDNA-M50, pcDNA-M50-
Flag, pcDNA-m144-Flag, and pcDNA-UL56-Flag were generated
by PCR amplification and insertion of the coding sequence
between the HindIII and XhoI sites of pcDNA3. Plasmids
encoding N- and C-terminal truncations of M50 were generated
in the same way. Deletions within the M50 variable region were
made as described [39]. Substitutions of the M50 TM domain
were made using a three-step PCR-based procedure essentially as
described elsewhere [69]. pcDNA-UL50-Flag and pcDNA-CNX-
Flag were also generated by PCR cloning using the EcoRI and
XhoI sites of pcDNA3. The K599A mutation was introduced by
QuikChange site-directed mutagenesis (Stratagene) into pcDNA-
IRE1-HA. Transient transfections were done using ployethylenei-
mine (Sigma) or PolyFect transfection reagent (Qiagen) according
to the manufacturer’s protocol. Within each experiment, the total
amount of transfected DNA was kept constant by addition of
empty vector plasmid. Tunicamycin, thapsigargin, puromycin,
and protease inhibitor cocktail (104 mM AEBSF, 80 mM Apro-
tinin, 4 mM Bestatin, 1.4 mM E-64, 2 mM Leupeptin, 1.5 mM
Pepstatin A) were purchased from Sigma, MG132 from Merck,
and lactacystin from Biomol.
Retroviral transduction
HA-tagged murine IRE1a was PCR amplified, digested with
BglII and XbaI, and inserted into pMSCVpuro (Clontech).
Murine IRE1a with a 3xmyc tag was PCR amplified, digested
with BglII and HpaI, and inserted into pMSCVhyg (Clontech).
HA-tagged human IRE1a was excised from pcDNA-hIRE1-HA
and inserted between the PmlI and XhoI sites of pRetroEBNA
[70]. Retrovirus production using the Phoenix packaging cell line
and transduction of target cells was done as described [71]. Cells
transduced with MSCVpuro vectors were selected with 6 mg/ml
puromycin (Sigma) and cells transduced with MSCVhyg vectors
were selected with 200 mg/ml hygromycin B (PAA Laboratories).
Affinity purification and mass spectrometry
NIH-3T3 cells were transfected with pBRep-IRE1-TEV-HA
and selected as bulk culture for 14 days with 200 mg/ml
hygromycin B. IRE1-TEV-HA expression was verified by
immunoblot. 86107 cells were mock treated or MCMV infected
at an MOI of 1. After 48 h, cells were lysed with RIPA buffer
(50 mM Tris pH 7.2, 150 mM NaCl, 1% TritonX100, 0.1%
SDS, 1% sodium deoxycholate, and Complete protease inhibitor
cocktail [Roche]) and centrifuged for 10 min at 16000 g.
Supernatants were loaded onto anti-HA 3F10 affinity columns
(Roche) and washed with 20 mM Tris-HCl pH 7.5, 0.1 M NaCl,
0.1 M EDTA, 0.05% Tween-20. IRE1 and associated proteins
were eluted by digestion with 100 units of AcTEV protease
(Invitrogen) for 1 h at room temperature. Eluted proteins were
concentrated with StrataClean resin beads, separated by SDS-
PAGE, and silver-stained [52]. In-gel digestion of excised gel
bands was done as described [72]. Peptide extracts were analyzed
Figure 7. Modulation of the IRE1-XBP1 pathway by HCMV UL50. (A) 293A cells were cotransfected with plasmids expressing HA-tagged
murine or human IRE1 and Flag-tagged M50, UL56, NEMO, or UL50 respectively. Cell lysates were harvested 24 h after transfection. IRE1 was
immunoprecipitated (IP) with an anti-HA antibody. IRE1 and coexpressed proteins were detected by immunoblot in IP samples and whole cell lysates
(WCL) using anti-HA and anti-Flag antibodies, respectively. (B) HFF cells were cotransfected with plasmids encoding IRE1-HA (1 mg) and Flag-tagged
HCMV UL50 or HSV-1 UL56 (2 mg). After 24 h, IRE1 levels were determined by immunoblot using an anti-HA antibody. UL50 and UL56 were detected
with an anti-Flag antibody. (C) MRC-5 cells transduced with a retroviral vector expressing HA-tagged human IRE1 were infected with HCMV at an MOI
of 3. At the indicated time points cells were harvested, and IRE1 levels were determined by immunoblot. HCMV IE1 and IE2 and b-actin were detected
as infection and loading controls, respectively. (D) MRC-5 cells were infected with HCMV at an MOI of 3 and treated with Tun for the last 4 h before
harvest. Spliced and unspliced XBP1 transcripts were quantified by real-time RT-PCR. Changes in the spliced/unspliced ratio are shown relative to
untreated cells (means 6SEM of three replicates).
doi:10.1371/journal.ppat.1003544.g007
IRE1 Downregulation by CMV
PLOS Pathogens | www.plospathogens.org 11 August 2013 | Volume 9 | Issue 8 | e1003544
on an Orbitrap XL mass spectrometer (Thermo Scientific), online
coupled to a bioinert Ultimate 3000 nano HPLCs (Thermo
Scientific). Peptides were pre-concentrated on a self-packed
Synergi HydroRP trapping column (100 mm ID, 4 mm particle
size, 100 Å pore size, 2 cm length) and separated on a self-packed
Synergi HydroRP main column (75 mm ID, 2.5 mm particle size,
100 Å pore size, 30 cm length) at 60uC and a flow rate of 270 nL/
min using a binary gradient (A: 0.1% formic acid, B: 0.1% formic
acid, 84% acetonitrile) ranging from 5% to 50% B in 40 min.
After each sample a dedicated wash blank was applied to clean the
columns. MS survey scans were acquired from 350–2000 m/z in
the Orbitrap with a resolution of 60,000 using the polysiloxane m/
z 445.120030 as lock [73]. The five most intense signals were
subjected to MS/MS in the LTQ with a normalized collision
energy of 35 and a dynamic exclusion of 30 s. Automatic gain
control target values were set to 106 for MS and 104 for MS/MS
scans. Raw data were searched with the Proteome Discoverer
Software 1.2 (Thermo Scientific) and Mascot 2.2 (Matrix Science)
against Uniprot mouse and murid herpesvirus 1 databases. Search
settings were as follows: (i) Trypsin as enzyme with a maximum of
two missed cleavage sites, (ii) carbamidomethylation of Cys as
fixed modification, (iii) phosphorylation of Ser/Thr/Tyr, and
oxidation of Met as variable modifications, (iv) MS and MS/MS
tolerances of 10 ppm and 0.5 Da, respectively. Only proteins with
at least two peptides having (i) a Mascot score above 35 and (ii) a
mass deviation #4 ppm and (iii) between 6 and 22 amino acids,
were considered for data evaluation
Immunoprecipitation and immunoblot analysis
For immunoprecipitation 293A cells were transfected in 10 cm
dishes and lysed after 24 h with RIPA buffer. Insoluble material
was removed by centrifugation. Proteins were precipitated using
antibodies against HA, Flag, or myc epitopes and protein A or
protein G Sepharose (GE Healthcare), respectively, washed 6
times, eluted by boiling in sample buffer, and subjected to SDS-
PAGE and immunoblotting.
For immunoblot analysis whole cell lysates were analyzed using
antibodies against Flag epitope (M2 or F7425, Sigma), HA epitope
(16B12, Covance Inc., or 3F10, Roche), myc epitope (4A6,
Millipore), b actin (AC-74, Sigma), MCMV IE1 (CROMA101;
provided by Stipan Jonjic, University of Rijeka, Croatia), HCMV
IE1/2 (3H4; provided by Thomas Shenk, Princeton University,
USA), M50 [34], M55/gB (SN1.07, provided by Stipan Jonjic),
BiP (E-4, Santa Cruz); IRE1a (14C10, Cell Signaling), IRE1a[p-
Ser724] (Novus Biologicals), XBP1s (M-186, Santa Cruz), HP1a
(Cell Signaling), p53 (FL-393, Santa Cruz). Secondary antibodies
coupled to horseradish peroxidase were purchased from Dako.
Immunofluorescence
NIH-3T3 or 10.1 cells were transfected or infected on
coverslips, washed with PBS, and fixed for 20 min in 4%
paraformaldehyde in PBS. Cells were incubated with 50 mM
ammonium chloride, permeabilized with 0.3% TritonX-100, and
blocked with 0.2% cold-water fish skin gelatin (Sigma) and 2%
horse serum (when the anti-M50 antiserum was used). Cells were
Figure 8. IRE1 functions and inhibition by M50 and UL50. Accumulation of unfolded proteins in the ER leads to recruitment of chaperones
such as BiP and activation of ER stress sensors such as IRE1. (A) IRE1 dimerizes, autophosphorylates itself, and activates an endoribonuclease activity,
which mediates Xbp1 mRNA splicing. The XBP1s protein activates transcription of ERAD genes such as ERdj4. (B) MCMV M50 and HCMV UL50 interact
with IRE1 and induce IRE1 degradation, thereby inhibiting the IRE1-XBP1 pathway shown in A. (C) Activated IRE1 can also cleave certain glycoprotein
(gp)-encoding mRNAs and microRNAs. (D) Recruitment of TRAF2 by activated IRE1 can lead to JNK or caspase-12 activation and subsequent
induction of apoptosis.
doi:10.1371/journal.ppat.1003544.g008
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then incubated with primary antibodies for 1 h at room
temperature (RT), washed three times with PBS, and incubated
for 1 h with secondary antibodies coupled to AlexaFluor555 or
AlexaFluor488 (Invitrogen). Nuclei were stained using Draq5
(BioStatus). Samples were washed, mounted on slides with Aqua-
Poly/Mount (Polysciences), and analyzed by confocal laser
scanning microscopy using a Zeiss LSM510 Meta microscope.
The Pearson correlation coefficient was calculated using JACoP
for ImageJ [74].
Pulse-chase experiment
293T cells were transfected with pcDNA-IRE1-HA and
pcDNA-M50 at a 1:4 ratio using polyethyleneimine. 48 h after
transfection cells were incubated with methionine-deficient
DMEM for 45 min and pulse-labeled with 35S-methionine
(IsoLabel L-[35S], Izotop, Hungary) for 30 min. Cell were chased
for up to 4 h in DMEM containing 50-fold excess of cold
methionine. Cells were then harvested and lysed as described
previously [75]. HA-tagged IRE1 was immunoprecipitated with
12CA5 anti-HA monoclonal antibody and protein G-conjugated
sepharose (Santa Cruz). Immunoprecipitates were washed exten-
sively with NET buffer containing 0.1% SDS, boiled in Laemmli
sample buffer and separated by SDS-PAGE. The gel was
processed for autoradiography as previously described [75].
RNA isolation and RT-PCR
Total RNA was isolated from murine fibroblasts using innuPREP
RNA Mini Kit (analytik-jena). After DNase treatment (Turbo
DNA-free Kit, Ambion) cDNA was synthesized from 1 mg RNA
using 200 U RevertAid H Minus Reverse Transcriptase, 100 pmol
Oligo[dT]18, and 20 U RNase inhibitor (Thermo Scientific). For
semiquantitative analysis, murine Xbp1 was amplified by using
primers 59-AAACAGAGTAGCAGCGCAGACTGC-39 and 59-
AAACAGAGTAGCAGCGCAGACTG C-39. Primers 59-GCCA-
GAGGAGGAACGAGCT-39 and 59-GGGCCTTTTCATTGTT
TTCCA-39 were used to amplify c-myc. PCR reaction was
performed under the following conditions: 40 cycles of 30 s at
95uC, 30 s at 48uC, and 30 s at 72uC. PCR products were digested
with PstI and analyzed on an ethidium bromide-stained agarose gel
as described [76].
Quantitative RT-PCR reactions employing SYBR Green
fluorescent reagent (Applied Biosystems) were run in an Applied
Biosystems 7900HT Fast Real-Time PCR System. The following
primers were used: 59-GAGTCCGCAGCAGGTG-39 and 59-
GTGTCAGAGTCCATGGGA-39 murine Xbp1s, 59-GTGTCA-
GAGTCCATGGGA-39 and 59-GTGTCAGAGTCCATGGGA-
39 for murine Xbp1u, 59-GAGTCCGCAGCAGGTG-39 and 59-
CAATACCGCCAGAATCCA-39 for human XBP1s, 59-CACT-
CAGACTATGTGCACCTC-39 and 59-CAATACCGCCAGAA-
TCCA-39 for human XBP1u, 59-ATAAAAGCCCTGATGCT-
GAAGC-39 and 59-GCCATTGGTAAAAGCACTGTGT-39 for
murine ERdj4, 59-CGGCCTTTGCTGATAGTCTC-39 and 59-
AGTTACCACCAGTCCATCGC-39 for murine Ire1 and 59-
CCCACTCTTCCACCTTCGATG-39 and 59-GTCCACCAC-
CCTGTTGCTGTAG-39 for human and murine GAPDH.
Reactions were performed under the following conditions: 45
cycles of 3 s at 95uC and 30 s at 60uC. Three or four replicates
were analyzed for each condition, and the relative amounts of
mRNAs were calculated from the comparative threshold cycle (Ct)
values by using GAPDH as reference.
Accession numbers
GenBank accession numbers of proteins and genes mentioned
in this study: murine ATF4 (NP_033846), ATF6 (NP_001074773),
BiP (P20029), BI-1 (NP_001164507), CNX (P35564), ERdj4
(NM_013760), GAPDH (NM_008084), IRE1 (AF071777), IRE2
(Q9Z2E3), PERK (NP_034251), SYVN1 (NP_001158181),
XBP1s (NM_001271730), XBP1u (NM_013842); human EDEM
(NP_055489), ERdj4 (NM_012328), GAPDH (NM_002046),
IRE1 (NM_001433), XBP1s (NM_001079539), XBP1u
(NM_005080); MCMV IE1 (P11210), m41 (ADD10423), M50
(ADD10432), M53 (ADD10435), M55 (ADD10436), M85
(ADD10456), m144 (ADD10510); HCMV IE1 (P13202), IE2
(P19893), UL50 (P16791); HSV-1 UL56 (AEQ77088).
Supporting Information
Figure S1 IRE1 downregulation by M50 in the presence
of M53. NIH-3T3 cells were cotransfected with plasmids
encoding IRE1-HA (1 mg) and M50 (2 mg), and Ig-tagged M53
(1 or 2 mg). After 24 h, cell lysates were analyzed by immunoblot
using protein- or tag-specific antibodies.
(TIF)
Figure S2 Downregulation of IRE1 in ts20 cells and
NIH-3T3 cells treated with different lysosomal inhibi-
tors. (A) ts20 cells were cotransfected with plasmids encoding HA-
tagged IRE1 (1 mg) and M50 (0, 2, 3 mg) and incubated at 35 or
40uC for 24 h. At 40uC, the cellular E1 ubiquitin-activating enzyme
is inactive. IRE1, M50, and b-actin were detected with protein- or
tag-specific antibodies. (B) NIH-3T3 cells were cotransfected with
expression plasmids for IRE1-HA and M50. Transfected cells were
treated for 6 h with MG132 (10 mM) or for 24 h with lactacystin
(10 mM) harvested 24 h after transfection. IRE1, M50, p53 and b-
actin were detected with protein- or tag-specific antibodies.
Inhibition of p53 degradation by MG132 and lactacystin was used
as positive control. (C) NIH-3T3 cells were cotransfected with
expression plasmids for IRE1-HA and M50. 7 h after transfection,
cells were treated for 24 h with a lysosomal protease-inhibitor (PI)
mix (1:200) or NH4Cl (10 mM). IRE1, M50, and b-actin were
detected with protein- or tag-specific antibodies.
(TIF)
Figure S3 IRE1 interaction and intracellular localiza-
tion of mutant M50 proteins. (A) 293A cells were cotrans-
fected with expression plasmids for IRE1-HA and full-length (fl.)
or mutant M50. IRE1 was immunoprecipitated (IP) with an anti-
HA antibody, and coprecipitating M50 proteins were detected by
immunoblot using an M50-specific antibody. The M50 1–178,
277–317 mutant was detected using an anti-Flag antibody. The
same proteins were detected in whole cell lysates (WCL). LC,
antibody light chain. (B) NIH-3T3 cells were cotransfected with
expression plasmids for IRE1-HA and fl. or mutant M50. 24 h
post transfection, cells were fixed and subjected to immunofluo-
rescence staining using HA- and M50-specific antibodies. Cell
nuclei were stained with Draq5. The Pearson correlation
coefficient (PC) was determined for transfected cells.
(TIF)
Figure S4 Ire1 transcript levels in MCMV-infected cells.
10.1 fibroblasts stably expressing myc-tagged IRE1 were infected
with an MCMV M50 deletion mutant (DM50) or the parental
control virus at an MOI of 3. Cells were harvested at 0, 24, and
48 hpi. Ire1 transcripts were quantified by real-time RT-PCR.
Mean 6SEM of three replicates are shown relative to uninfected
cells.
(TIF)
Figure S5 Induction of BiP during MCMV infection. 10.1
fibroblasts were infected with MCMV at an MOI of 5 or treated
with 1 mM thapsigargin (Tg) for 8 h. Cell lysates were harvested at
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